MedTrace Logo

Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer

NCT01015625 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2024-08-19

Study results available
· View outcomes & findings →

Summary

Primary Operation in synchronous metastasized invasive breast cancer to evaluate the use of local therapy

Conditions

  • Synchronous Metastasized Breast Cancer
  • Circulating Tumor Cells

Interventions

PROCEDURE

Surgery

lumpectomy or mastectomy with or without radiotherapy. Sentinel biopsy followed by axillary dissection (level I-II)

PROCEDURE

Surgery on Demand

if necessary local therapy on demand

Sponsors & Collaborators

Principal Investigators

  • Florian Fitzal, MD · Austrian Breast & Colorectal Cancer Study Group

  • Michael Gnant, MD · Austrian Breast & Colorectal Cancer Study Group

  • Guenther Steger, MD · Austrian Breast & Colorectal Cancer Study Group

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-24
Primary Completion
2022-07-31
Completion
2022-07-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01015625 on ClinicalTrials.gov